Singer Capital Markets Securities Ltd, an exempt principal trader, disclosed dealings in relevant securities of HIPGNOSIS SONGS FUND LTD on 22 July 2024. The disclosed dealings included purchases of 8,475 ordinary shares at a price of 100.802p per unit. The disclosure also confirmed that there were no indemnity or other dealing arrangements, agreements, arrangements, or understandings relating to options or derivatives. The disclosure was made in accordance with Rule 8 of the Takeover Code.
The disclosure did not include any cash-settled derivative transactions, stock-settled derivative transactions, or other dealings such as subscribing for new securities. Additionally, there were no agreements, arrangements, or understandings relating to options or derivatives. The disclosure was made by Singer Capital Markets Securities Ltd in compliance with the regulatory requirements.
The information was disclosed on 23 July 2024, and the contact person for the disclosure is Jennifer Bentick, with a telephone number of 020 7496 3055. The disclosure was made to a Regulatory Information Service, as required by Rule 8 of the Code. The Panel's Market Surveillance Unit is available for consultation regarding the Code's dealing disclosure requirements.
This disclosure provides transparency regarding the dealings in relevant securities of HIPGNOSIS SONGS FUND LTD by Singer Capital Markets Securities Ltd, ensuring compliance with the regulatory framework and promoting market integrity.